157 related articles for article (PubMed ID: 9038732)
61. The pathology of cervical tumours.
Tiltman AJ
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):485-500. PubMed ID: 16150389
[TBL] [Abstract][Full Text] [Related]
62. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
63. E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium.
Heatley MK
Histopathology; 2004 Aug; 45(2):200-2. PubMed ID: 15279644
[No Abstract] [Full Text] [Related]
64. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
[TBL] [Abstract][Full Text] [Related]
65. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.
Sano T; Oyama T; Kashiwabara K; Fukuda T; Nakajima T
Pathol Int; 1998 Aug; 48(8):580-5. PubMed ID: 9736404
[TBL] [Abstract][Full Text] [Related]
66. Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis.
Lu H; Gan M; Zhang G; Zhou T; Yan M; Wang S
Eur J Gynaecol Oncol; 2010; 31(6):662-6. PubMed ID: 21319512
[TBL] [Abstract][Full Text] [Related]
67. [The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix].
Nai MM; Yin RT; Xie C; Kang DY; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):236-9. PubMed ID: 19462897
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
Holm R; Skomedal H; Helland A; Kristensen G; Børresen AL; Nesland JM
J Pathol; 1993 Jan; 169(1):21-6. PubMed ID: 8433212
[TBL] [Abstract][Full Text] [Related]
69. Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
Chavez-Blanco A; Taja-Chayeb L; Cetina L; Chanona-Vilchis G; Trejo-Becerril C; Perez-Cardenas E; Segura-Pacheco B; Acuña-González C; Dueñas-Gonzalez A
Int J Gynecol Pathol; 2002 Oct; 21(4):368-74. PubMed ID: 12352185
[TBL] [Abstract][Full Text] [Related]
70. Relationship between human papillomavirus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases.
Cavuslu S; Goodlad J; Hobbs C; Connor AM; Raju KS; Best JM; Cason J
J Med Virol; 1997 Oct; 53(2):111-7. PubMed ID: 9334921
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
72. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix.
Koay MH; Crook M; Stewart CJ
Pathology; 2014 Aug; 46(5):433-8. PubMed ID: 24977742
[TBL] [Abstract][Full Text] [Related]
73. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
75. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
76. Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms.
Huang LW; Chao SL; Hwang JL; Chou YY
Gynecol Oncol; 2002 Jun; 85(3):524-8. PubMed ID: 12051885
[TBL] [Abstract][Full Text] [Related]
77. Role and significance of HER-2/neu as a biomarker in the premalignant and malignant lesions of uterine cervix.
Varshney S; Maheshwari V; Aijaz M; Alam K
Ann Diagn Pathol; 2020 Apr; 45():151443. PubMed ID: 31923745
[TBL] [Abstract][Full Text] [Related]
78. Cell-cycle analysis and apoptosis-associated proteins in cervical lesions of Brazilian women.
Dobo C; Oshima CT; De Oliveira Lima F; Gomes TS; Stávale JN; Arias V; Ribeiro DA; Focchi GR
Anticancer Res; 2014 Jun; 34(6):2789-96. PubMed ID: 24922640
[TBL] [Abstract][Full Text] [Related]
79. [Expression and significance of Smad2/3 and HPV16 E7 in cervical intraepithelial neoplasia and cervical carcinoma].
Tian Y; Wu P; Luo AY; Xi L; Zhou JF; Ma D
Ai Zheng; 2007 Sep; 26(9):967-71. PubMed ID: 17927854
[TBL] [Abstract][Full Text] [Related]
80. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
